One option is Wegovy (semaglutide) , which is also highly effective, clinically proven, and may be more cost-effective than Mounjaro
doi: 10.1152/ajpendo.00153.2015 122 BurkeSJGoffMRUpdegraffBLLuDBrownPLMinkinSCJr.et al
Food and Drug Administration (FDA) approval in May 2022 for type 2 diabetes, November 2023 for chronic weight management, and December 2024 for obstructive sleep apnea, marking it as the first approved therapy for this indication
Quiets the wired-but-tired loop When cortisol stays elevated at night, you can't switch into sleep mode
Abnormal glutathione levels in the body have been linked to Alzheimer's disease, AIDS, cancer, liver damage, cardiovascular disease and other diseases